Foccini International Inc.

(FOI:APH)

By |

Profile

Arch Biopartners Inc is a portfolio based biotechnology company. It focuses on the development of innovative technologies. The company's portfolio of technology includes AB569 which is a new drug candidate for treating antibiotic-resistant bacterial infections, primarily in the lungs and urinary tract; MetaBlok which is a new drug candidate targeting sepsis, cancer metastasis and inflammation based diseases; Arch Inflammation which is a novel treatment for chronic kidney and bowel diseases caused by non-infectious inflammation. It also develops Borg technology which is a solid surface interface to solid metal and plastic surfaces to inhibit biofilm formation and reduce corrosion; and MetaMx which is a synthetic molecule that targets brain tumor-initiating cells and invasive glioma cells.

Contact Information

Website: www.archbiopartners.com
Email: info@archbiopartners.com
Main Phone: +1 647 428-7031
Address: 545 King Street West
State: ON
City / Town: Toronto
Country: CAN
Postal Code: M5V 1M1

Issuer Information

Exchange: CDX
CEO: Richard Muruve
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Arch Biopartners Inc is a portfolio based biotechnology company. It focuses on the development of innovative technologies. The company's portfolio of technology includes AB569 which is a new drug candidate for treating antibiotic-resistant bacterial infections, primarily in the lungs and urinary tract; MetaBlok which is a new drug candidate targeting sepsis, cancer metastasis and inflammation based diseases; Arch Inflammation which is a novel treatment for chronic kidney and bowel diseases caused by non-infectious inflammation. It also develops Borg technology which is a solid surface interface to solid metal and plastic surfaces to inhibit biofilm formation and reduce corrosion; and MetaMx which is a synthetic molecule that targets brain tumor-initiating cells and invasive glioma cells.

Contact Information

Website: www.archbiopartners.com
Email: info@archbiopartners.com
Main Phone: +1 647 428-7031
Address: 545 King Street West
State: ON
City / Town: Toronto
Country: CAN
Postal Code: M5V 1M1

Issuer Information

Exchange: CDX
CEO: Richard Muruve
NAICS: Pharmaceutical Preparation Manufacturing(325412)
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange TSXV